Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIT HEADS 3.0: BCAAs in the Treatment of Concussion
NCT07670195Phase 2Recruiting
- Start
- Aug 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of Branchamin in concussion (mTBI), traumatic brain injury (TBI). Started Aug 2026; status: recruiting.
02
Drugs
Branchamin
03
Conditions
concussion (mTBI)traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT07670195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07670195.